While the US policy changes with Cuba and the cyber attack on Sony Pictures Entertainment, which the FBI said on 19 December was carried out by the North Korean government, took center stage at President Barack Obama's final press conference of the year, he also provided his perspective on what's ahead for tax reform in 2015 and efforts to stop inversion.
While the US policy changes with Cuba and the cyber attack on Sony Pictures Entertainment, which the FBI said on 19 December was carried out by the North Korean government, took center stage at President Barack Obama's final press conference of the year, he also provided his perspective on what's ahead for tax reform in 2015 and efforts to stop inversion.
President Obama said he plans to put forward "some pretty specific proposals" in 2015, building on what he and his...
Optimizing Drug Pipelines With Biophysical Methods”, your view into how using biophysical techniques can enhance and streamline processes throughout the drug discovery and validation cycle.
CEO Paul Stoffels said gaining US clearance for an IND for its novel CAR-T product was demanding, but now opens up a pathway towards a pivotal study starting in 2025.
A final rejection of Leqembi could also spell the same fate for Lilly’s rival drug but public outcry and demand for Alzheimer’s therapies might force the regulator’s hand
GSK will assume full control of mRNA shots in infectious disease, allowing CureVac to cut costs and pivot its research to oncology.
As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.
Lilly's first Phase III triplet win opens the door to a label expansion in BTK-pretreated CLL, with analysts suggesting Jaypica could attain blockbuster status. However, the window to capitalize may be brief as next-generation BTK degraders close in with head-to-head trials.
Lilly's first Phase III triplet win opens the door to a label expansion in BTK-pretreated CLL, with analysts suggesting Jaypica could attain blockbuster status. However, the window to capitalize may be brief as next-generation BTK degraders close in with head-to-head trials.
